Diligence memo · auto-generated · as of July 2, 2026
Sequoia Pharmaceuticals Inc
Sequoia Pharmaceuticals Inc looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
Sequoia Pharmaceuticals Inc operates in Pharmaceuticals, based in GAITHERSBURG.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sequoia Pharmaceuticals Inc has raised $3.8M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.8M on 2009-06-02.
Most recent recorded round closed around 2009-06-02.
Valuation (modeled)modeled
Provath models Sequoia Pharmaceuticals Inc at approximately $145M (range $2.9M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.79× the median modeled value of Seed Pharmaceuticals companies in 2007–2009 (25 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 17.1 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 37% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 62% of those peers.
Closest niche peers: Spring Pharmaceuticals, LLC, Oceana Therapeutics, Inc., Supergen Inc, Archer Pharmaceuticals, Inc., Cequent Pharmaceuticals Inc.
Peoplefiled
8 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.